Skip to main content Deutsch


Barbara Niederdorfer
Barbara Niederdorfer, MSc, PhD

Department of Medicine I (Division of Oncology)
Position: Research Associate (Postdoc)

ORCID: 0000-0002-6324-7524

Further Information


Biomarkers, Pharmacological; Immune Evasion; Methylation

Research group(s)

Research interests

The main aim of my group is to identify a 360° biomarker including among others tissue- and blood-based information of a particular patient for prediction of response to immune checkpoint-inhibition.

Selected publications

  1. Niederdorfer, B. et al. (2020) ‘Strategies to Enhance Logic Modeling-Based Cell Line-Specific Drug Synergy Prediction’, Frontiers in Physiology, 11. Available at:
  2. Tsirvouli, E. et al. (2020) ‘A Middle-Out Modeling Strategy to Extend a Colon Cancer Logical Model Improves Drug Synergy Predictions in Epithelial-Derived Cancer Cell Lines’, Frontiers in Molecular Biosciences, 7. Available at:
  3. Flobak, Å. et al. (2019) ‘A high-throughput drug combination screen of targeted small molecule inhibitors in cancer cell lines’, Scientific Data, 6(1). Available at:
  4. Folkesson, E. et al. (2020) ‘High-throughput screening reveals higher synergistic effect of MEK inhibitor combinations in colon cancer spheroids’, Scientific Reports, 10(1). Available at: